Sheffield Institute for Translational Neuroscience, University of Sheffield, 385A Glossop Road, Sheffield, S10 2HQ, UK.
Institute for Health and Society, University of Newcastle, Newcastle upon Tyne, UK.
Acta Neuropathol Commun. 2019 Dec 5;7(1):198. doi: 10.1186/s40478-019-0858-4.
Aβ-amyloid deposition is a key feature of Alzheimer's disease, but Consortium to Establish a Registry for Alzheimer's Disease (CERAD) assessment, based on neuritic plaque density, shows a limited relationships to dementia. Thal phase is based on a neuroanatomical hierarchy of Aβ-deposition, and in combination with Braak neurofibrillary tangle staging also allows derivation of primary age-related tauopathy (PART). We sought to determine whether Thal Aβ phase predicts dementia better than CERAD in a population-representative cohort (n = 186) derived from the Cognitive Function and Ageing Study (CFAS). Cerebral amyloid angiopathy (CAA) was quantitied as the number of neuroanatomical areas involved and cases meeting criteria for PART were defined to determine if they are a distinct pathological group within the ageing population. Agreement with the Thal scheme was excellent. In univariate analysis Thal phase performed less well as a predictor of dementia than CERAD, Braak or CAA. Logistic regression, decision tree and linear discriminant analysis were performed for multivariable analysis, with similar results. Thal phase did not provide a better explanation of dementia than CERAD, and there was no additional benefit to including more than one assessment of Aβ in the model. Number of areas involved by CAA was highly correlated with assessment based on a severity score (p < 0.001). The presence of capillary involvement (CAA type I) was associated with higher Thal phase and Braak stage (p < 0.001). CAA was not associated with microinfarcts (p = 0.1). Cases satisfying pathological criteria for PART were present at a frequency of 10.2% but were not older and did not have a higher likelihood of dementia than a comparison group of individuals with similar Braak stage but with more Aβ. They also did not have higher hippocampal-tau stage, although PART was weakly associated with increased presence of thorn-shaped astrocytes (p = 0.048), suggesting common age-related mechanisms. Thal phase is highly applicable in a population-representative setting and allows definition of pathological subgroups, such as PART. Thal phase, plaque density, and extent and type of CAA measure different aspects of Aβ pathology, but addition of more than one Aβ measure does not improve dementia prediction, probably because these variables are highly correlated. Machine learning predictions reveal the importance of combining neuropathological measurements for the assessment of dementia.
β-淀粉样蛋白沉积是阿尔茨海默病的一个关键特征,但基于神经突斑块密度的 Consortium to Establish a Registry for Alzheimer's Disease(CERAD)评估与痴呆的相关性有限。Thal 分期基于 Aβ 沉积的神经解剖学层次结构,与 Braak 神经原纤维缠结分期相结合,还可以得出原发性年龄相关性 tau 病(PART)。我们试图确定在认知功能和衰老研究(CFAS)中从代表性人群中得出的队列(n=186)中,Thal Aβ 分期是否比 CERAD 更能预测痴呆。脑淀粉样血管病(CAA)的定量方法是涉及的神经解剖区域的数量,并确定是否符合 PART 标准的病例是否是老年人群中的一个独特病理组。与 Thal 方案的一致性非常好。在单变量分析中,Thal 分期作为痴呆的预测指标不如 CERAD、Braak 或 CAA 表现好。进行了逻辑回归、决策树和线性判别分析的多变量分析,结果相似。Thal 分期并没有比 CERAD 更好地解释痴呆,而且在模型中纳入超过一种 Aβ 评估并不能带来额外的好处。CAA 受累区域的数量与基于严重程度评分的评估高度相关(p<0.001)。毛细血管受累(CAA Ⅰ型)与更高的 Thal 分期和 Braak 分期相关(p<0.001)。CAA 与微梗死无关(p=0.1)。符合 PART 病理标准的病例频率为 10.2%,但与具有相似 Braak 分期但具有更多 Aβ的对照组相比,年龄并不更大,痴呆的可能性也没有更高。他们也没有更高的海马体 tau 分期,尽管 PART 与棘状星形胶质细胞的存在增加呈弱相关(p=0.048),这表明存在共同的与年龄相关的机制。Thal 分期在代表性人群中具有高度适用性,并允许定义病理亚组,如 PART。Thal 分期、斑块密度以及 CAA 的范围和类型测量了 Aβ 病理学的不同方面,但增加一种以上的 Aβ 测量并不能改善痴呆预测,这可能是因为这些变量高度相关。机器学习预测揭示了将神经病理学测量结合起来评估痴呆的重要性。